On Mar. 16, 2022, Moderna announced an agreement with the Ministry of Health, Labour and Welfare of Japan to supply Japan with an additional 70 million doses of Moderna’s COVID-19 booster vaccine or an updated booster vaccine candidate, if authorized, for anticipated delivery in the second half of 2022.

This agreement is subject to the Ministry securing a budget for the additional supply. In 2022, 93 million doses of Moderna’s COVID-19 vaccine are currently contracted for supply to Japan, with the potential for this to increase to 163 million doses with this new agreement.